Skip to main content
. 2016 Oct 31;6:35983. doi: 10.1038/srep35983

Figure 2. Female ubc13+/− mice are protected against age-related and HFD-induced insulin resistance.

Figure 2

(A–C) Blood glucose (A) and serum insulin (B) levels during OGTT and blood glucose (C) levels during ITT were measured for female WT and ubc13+/− mice at 8 weeks of age on ND (n = 4). (D–F) Blood glucose (D) and serum insulin (E) levels during OGTT and blood glucose (F) levels during ITT were measured for female WT and ubc13+/− mice at 18 weeks of age on ND (n = 6). *p < 0.05, **p < 0.01 versus WT mice. (G–I) Blood glucose (G) and serum insulin (H) levels during OGTT and blood glucose (I) levels during ITT were measured for female WT and ubc13+/− mice after 14 weeks of HFD (n = 5 to 6). HFD was started at 4 weeks of age. *p < 0.05, **p < 0.01 versus HFD-fed WT mice.